7CZF image
Deposition Date 2020-09-08
Release Date 2020-10-21
Last Version Date 2024-10-30
Entry Detail
PDB ID:
7CZF
Keywords:
Title:
Crystal structure of Kaposi Sarcoma associated herpesvirus (KSHV ) gHgL in complex with the ligand binding domian (LBD) of EphA2
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.20 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Ephrin type-A receptor 2
Gene (Uniprot):EPHA2
Chain IDs:A, D
Chain Length:185
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein H
Gene (Uniprot):ORF22
Chain IDs:B, E
Chain Length:677
Number of Molecules:2
Biological Source:Human herpesvirus 8
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein L
Gene (Uniprot):ORF47
Chain IDs:C, F
Chain Length:157
Number of Molecules:2
Biological Source:Human herpesvirus 8
Ligand Molecules
Primary Citation
Molecular basis of EphA2 recognition by gHgL from gammaherpesviruses.
Nat Commun 11 5964 5964 (2020)
PMID: 33235207 DOI: 10.1038/s41467-020-19617-9

Abstact

The human γ-herpesviruses Kaposi sarcoma associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) are associated with many human malignancies. Viral glycoprotein H (gH) and glycoprotein L (gL) are crucial for the cell tropism by binding to specific receptors. Recently, EphA2 was identified as the specific entry receptor for both KSHV and EBV. Here, we characterized the crystal structures of KSHV gHgL or EBV gHgL in complex with the ligand binding domain (LBD) of EphA2. Both KSHV and EBV gHgL bind to the channel and peripheral regions of LBD primarily using gL. Extensive interactions with more contacts contribute to the higher affinity of KSHV gHgL to LBD than that of EBV gHgL. These binding characteristics were verified using cell-based fusion assays with mutations in key EphA2 residues. Our experiments suggest that multiple animal γ-herpesviruses could use EphA2 as an entry receptor, implying a potential threat to human health.

Legend

Protein

Chemical

Disease

Primary Citation of related structures